(-0.13%) 5 462.10 points
(-0.10%) 39 075 points
(0.09%) 17 734 points
(-0.66%) $80.30
(-4.32%) $2.64
(-0.76%) $2 313.10
(0.13%) $28.91
(2.33%) $1 009.40
(0.29%) $0.936
(0.72%) $10.68
(0.48%) $0.792
(-0.14%) $87.37
Live Chart Being Loaded With Signals
As of January 3, 2023, Oyster Point Pharma, Inc. was acquired by Viatris Inc. Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States...
Stats | |
---|---|
Today's Volume | 2.09M |
Average Volume | 417 562 |
Market Cap | 0.00 |
EPS | $-1.500 ( Q3 | 2022-11-10 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.261 (2.34%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-01-03 | Invopps Gp Iv, L.l.c. | Sell | 1 850 818 | Common Stock, par value $0.001 per share |
2023-01-03 | Invopps Gp Iv, L.l.c. | Sell | 1 850 818 | Common Stock, par value $0.001 per share |
2023-01-03 | Versant Venture Capital Vi, L.p. | Sell | 1 003 658 | Common Stock |
2023-01-03 | Versant Venture Capital Vi, L.p. | Sell | 1 003 658 | Common Stock |
2023-01-03 | Behbahani Ali | Sell | 10 066 | Common Stock |
INSIDER POWER |
---|
-99.07 |
Last 100 transactions |
Buy: 1 389 418 | Sell: 22 126 304 |
Volume Correlation
Oyster Point Pharma, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Oyster Point Pharma, Inc. Correlation - Currency/Commodity
Oyster Point Pharma, Inc. Financials
Annual | 2021 |
Revenue: | $24.54M |
Gross Profit: | $23.01M (93.79 %) |
EPS: | $-3.87 |
FY | 2021 |
Revenue: | $24.54M |
Gross Profit: | $23.01M (93.79 %) |
EPS: | $-3.87 |
FY | 2020 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-2.92 |
FY | 2019 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-9.97 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Oyster Point Pharma, Inc.
As of January 3, 2023, Oyster Point Pharma, Inc. was acquired by Viatris Inc. Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company\'s product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry eye disease. It is also developing TYRVAYA that is in Phase II clinical trial for the treatment of for neurotrophic keratopathy. The company was incorporated in 2015 and is headquartered in Princeton, New Jersey.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators